Immune-Mediated Necrotizing Myopathy in Association with Statin Exposure

Read full text Summarise with VIRAT
Authors: Charlie E. Babcock, Phebie Rossi, Jennifer Hasvold
Cited by: 0
References: 11

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Statins are first-line therapy for hyperlipidemia and are widely prescribed in primary care. Although generally safe, they carry rare but serious risks that must be considered on an individual basis. One such complication is immune-mediated necrotizing myopathy (IMNM), an autoimmune condition characterized by persistent muscle weakness and elevated creatine kinase (CK) despite discontinuation of the statin. We describe an 87-year-old man with a history of atorvastatin intolerance who was reinitiated on the medication five years later. Shortly thereafter, he developed progressive weakness, recurrent hospitalizations, and ultimately was diagnosed with IMNM confirmed by biopsy and HMG-CoA reductase antibodies. Despite treatment with immunosuppressive therapy, his condition deteriorated, and he passed away. This case highlights IMNM as a critical diagnostic consideration in patients presenting with persistent myalgias and CK elevation following statin withdrawal, underscoring the importance of early recognition and intervention in improving outcomes.

Fields of Study & Subjects

Inflammatory Myopathies and Dermatomyositis Lipoproteins and Cardiovascular Health Drug-Induced Adverse Reactions

Publication details

Journal / source
Aesculapius
Volume
8
Issue
2026
Publication date
1 January 2026
Language
EN